Sara Lock
Impact in
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 3
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Stephen G Spiro (1 shared paper)David R. Lawrence (1 shared paper)Himender K. Makker (1 shared paper)Mahesh Parmar (1 shared paper)David Baldwin (1 shared paper)S. C.ONWAY MORRIS (1 shared paper)Matthew Guy Nankivell (1 shared paper)Sam M. Janes (1 shared paper)
- Journals
- The Lancet (6 papers)Nature Cancer (2 papers)Nature (2 papers)The Lancet Respiratory Medicine (2 papers)The Lancet. Gastroenterology & hepatology (1 paper)
- Partner nations
- United KingdomAustraliaVietnam
In The Last Decade
Sara Lock
17 papers receiving 5.3k citations
Sara Lock's Hit Papers
Peers
Comparison fields: 5 of 128
- Cancer Research 1.3k
- Oncology 1.9k
- Immunology 1.3k
- Infectious Diseases 970
- Pulmonary and Respiratory Medicine 1.1k
Countries citing papers authored by Sara Lock
This map shows the geographic impact of Sara Lock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Lock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Lock more than expected).
Fields of papers citing papers by Sara Lock
This network shows the impact of papers produced by Sara Lock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Lock. The network helps show where Sara Lock may publish in the future.
Co-authors
The 10 scholars most cited alongside Sara Lock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution Hit paper breakdown → | 2017 | 1449 |
| 2 | Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution Hit paper breakdown → | 2017 | 1015 |
| 3 | Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies Hit paper breakdown → | 2018 | 509 |
| 4 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 5 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 6 | 2017 | 369 | |
| 7 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 8 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 9 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 10 | 2015 | 208 | |
| 11 | 2022 | 92 | |
| 12 | 2023 | 83 | |
| 13 | 2020 | 73 | |
| 14 | 2019 | 59 | |
| 15 | 2021 | 51 | |
| 16 | 2019 | 48 | |
| 17 | 2025 | 22 | |
| 18 | 2025 | 0 | |
| 19 | 2026 | 0 | |
| 20 | 2026 | 0 |
About Sara Lock
Sara Lock is a scholar working on Oncology, Immunology, Cancer Research, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 20 papers that have together received 5.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (3 papers), CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.9k citations), Immunology (1.3k citations), Infectious Diseases (970 citations) and Pulmonary and Respiratory Medicine (1.1k citations). Sara Lock has collaborated with scholars based in United Kingdom, Australia and Vietnam. Frequent co-authors include Stephen G Spiro, David R. Lawrence, Himender K. Makker, Mahesh Parmar, David Baldwin, S. C.ONWAY MORRIS, Matthew Guy Nankivell, Sam M. Janes, Neal Navani and Richard J. Stephens. Their work appears in journals such as The Lancet, Nature Cancer, Nature, The Lancet Respiratory Medicine and The Lancet. Gastroenterology & hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.